Our vision is to deliver promising, transformative science to underserved patients. Our name symbolizes our mission to partner with clinicians and scientists to help people who are in urgent need.

Pipeline

Advancing novel therapeutics and radioimaging agents with standards of excellence in several degenerative disease areas.

Technology

Our world class research 

drives life-changing innovation for patients in oncology, neurology, and

rare pediatric diseases.

Partnerships

Collaborate with us to leverage our technologies and expertise to discover, develop, and deliver ground-breaking results to patients.

Our innovations in drug development help families to find a clearer pathway to diagnosis of children's rare diseases. That's impactful; and it's what drives us every day at AIP. 

Roseanne Satz, Chief Executive Officer and Founder

Our team has deep knowledge in radiation physics, leading to advances in the use of Positron Emission Tomography and Peptide Receptor Radionuclide Therapy.